Media

Filter by Category

All Blog News Newsletters Podcasts Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

The Honorable Jim Greenwood discusses the art and science of multi-stakeholder collaborations

The Honorable Jim Greenwood, President and CEO of Biotechnology Industry Organization (BIO) and C-Path Board member, participated

Critical Path Institute Receives Second Grant for Advancing Tuberculosis Treatments

WHO Collaborative registration procedure of prequalified medicines

U.S. Food and Drug Administration Continues Funding Critical Path Institute

The Patient-Reported Outcome (PRO) Consortium Lessons Learned Along the Path to PRO Instrument Qualification

Drs. Hudson and Stephenson take the ice bucket challenge

If Tuberculosis Spreads…

PRO Data Collection in Clinical Trials Using Mixed Modes: Report of the ISPOR PRO Mixed Modes Good Research Practices Task Force

January 7, 2014

Coalition Against Major Diseases/European Medicines Agency Biomarker Qualification Of Hippocampal Volume For Enrichment Of Clinical Trials In Predementia Stages Of Alzheimer’s Disease

Dr. Janet Woodcock, Director, Center for Drug Evaluation and Research, on FDA’s Critical Path Initiative

Previous107108 109...131 Next